Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 13.33% |
| TRI TECH HOL | TRIT | 10.29% |
| A M R CP | AAMRQ | 8.48% |
| JAZZ PHARMAC | JAZZ | 5.24% |
| SANTARUS INC | SNTS | 4.84% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Leucadia National Corporation ( LUK - Analyst Report ) posted its financial results for the fourth quarter and full year 2012 on Feb 25, 2013. Net results were impressive as earnings per share came in at $1.83 in the fourth quarter, compared with 46 cents earned in the year-ago quarter.
In 2012, earnings per share were $3.45, up compared with 5 cents reported in 2011.
Revenue
In 2012, consolidated revenue and other income were $9,193.7 million compared with $1,434.6 million in 2011. The year-over-year increase was primarily due to the inclusion of revenue contribution from National Beef Packaging Company, LLC, in which Leucadia acquired a controlling interest in Dec 2011.
During the year, revenue from the Beef Processing Services segment accounted for 81.4% of total revenue and settled at roughly $7.5 billion. Revenue from the Manufacturing segment was approximately $252.9 million, up 3.2% year over year and accounted for about 2.8% of total revenue.
Revenue generated from the Gaming Entertainment Operations segment was roughly 1.3% of total revenue, and stood at $119.3 million, while revenue of $10.9 million from the Domestic Real Estate segment accounted for 0.12% of total revenue.
Revenue from the Medical Product Development segment was $377 thousand compared with $378 thousand in the year-ago quarter. Proceeds from Other operations were $69.6 million versus $69.0 million in 2011 and accounted for about 0.8% of total revenue, while the Corporate segment revenue of $1,259.6 million accounted for about 13.7% of total revenue.
Expenses/Margins
Expenses increased from a mere $757.2 million in 2011 to $8.2 billion in 2012. The massive increase stems from $7.3 billion cost of sale related to the company’s beef processing services. In relation to revenue, expenses represented 89.5% compared with 52.8% in 2011.
Balance Sheet
Exiting the fourth quarter 2012, Leucadia’s cash and cash equivalents stood at roughly $146.0 million, way below $772.1 million in the previous quarter. Long-term debt balance was at $918.1 million compared with $911.8 million at the end of the third quarter.
Cash Flow
Cash flow from operating activities was roughly $221.9 million compared with just $9.1 million in 2011. Spending on property, equipment and leasehold improvements increased drastically in 2012 and totaled $71.3 million compared with $38.6 million in 2011.
Dividends paid amounted to $61.1 million, while no shares were repurchased during the year. Exiting 2012, the company was left with 25 million shares under its repurchase authorization.
Leucadia is engaged in beef processing, manufacturing, gaming entertainment, real estate activities, medical product development operations and various other investment-related activities in the United States. Other major players in the industry are China Merchants Holdings (International) Company Limited ( CMHHY ) , Jardine Strategic Holdings Ltd ( JSHLY ) and Koninklijke KPN N.V. ( KKPNF ) , each with a Zacks Rank #1 (Strong Buy).
Read the full Analyst Report on LUK
Read the full on JSHLY
Read the full on KKPNF
Read the full on CMHHY